These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19903149)

  • 1. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.
    Shi H
    Curr Med Chem; 2009; 16(34):4593-600. PubMed ID: 19903149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor-1: Regulatory mechanisms and drug development in stroke.
    Pan Z; Ma G; Kong L; Du G
    Pharmacol Res; 2021 Aug; 170():105742. PubMed ID: 34182129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke.
    Vatte S; Ugale R
    Neurochem Int; 2023 Nov; 170():105605. PubMed ID: 37657765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke.
    Yan J; Zhou B; Taheri S; Shi H
    PLoS One; 2011; 6(11):e27798. PubMed ID: 22110762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection.
    Harten SK; Ashcroft M; Maxwell PH
    Antioxid Redox Signal; 2010 Apr; 12(4):459-80. PubMed ID: 19737089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke.
    He Q; Ma Y; Liu J; Zhang D; Ren J; Zhao R; Chang J; Guo ZN; Yang Y
    Front Immunol; 2021; 12():801985. PubMed ID: 34966392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury.
    Chen W; Ostrowski RP; Obenaus A; Zhang JH
    Exp Neurol; 2009 Mar; 216(1):7-15. PubMed ID: 19041643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment.
    Guo S; Miyake M; Liu KJ; Shi H
    J Neurochem; 2009 Mar; 108(5):1309-21. PubMed ID: 19183269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases.
    Chen H; Ma D; Yue F; Qi Y; Dou M; Cui L; Xing Y
    Curr Neuropharmacol; 2022 Aug; 20(9):1651-1666. PubMed ID: 34325641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
    Shohet RV; Garcia JA
    J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.
    Semenza GL
    Biochim Biophys Acta; 2011 Jul; 1813(7):1263-8. PubMed ID: 20732359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
    Choi H; Chun YS; Kim SW; Kim MS; Park JW
    Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that collaboration between HIF-1α and Notch-1 promotes neuronal cell death in ischemic stroke.
    Cheng YL; Park JS; Manzanero S; Choi Y; Baik SH; Okun E; Gelderblom M; Fann DY; Magnus T; Launikonis BS; Mattson MP; Sobey CG; Jo DG; Arumugam TV
    Neurobiol Dis; 2014 Feb; 62():286-95. PubMed ID: 24141018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
    Zhang Z; Yan J; Taheri S; Liu KJ; Shi H
    Free Radic Biol Med; 2014 Mar; 68():8-21. PubMed ID: 24296245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen sensing in intestinal mucosal inflammation.
    Flück K; Fandrey J
    Pflugers Arch; 2016 Jan; 468(1):77-84. PubMed ID: 26206140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone has a synergistic effect with PHD inhibitors to ameliorate ischemic brain damage in mice.
    Amin N; Chen S; Ye S; Wu F; Hussien AB; Lou C; Hu Z; Wang Y; Wu J; Fang M
    Phytomedicine; 2022 Sep; 104():154298. PubMed ID: 35797865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.
    Kong L; Ma Y; Wang Z; Liu N; Ma G; Liu C; Shi R; Du G
    Int Immunopharmacol; 2021 May; 94():107507. PubMed ID: 33657523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
    Freeman RS; Barone MC
    Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):85-92. PubMed ID: 15723616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.
    Moon EJ; Sonveaux P; Porporato PE; Danhier P; Gallez B; Batinic-Haberle I; Nien YC; Schroeder T; Dewhirst MW
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20477-82. PubMed ID: 21059928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing hypoxic adaptation to prevent, treat, and repair stroke.
    Ratan RR; Siddiq A; Smirnova N; Karpisheva K; Haskew-Layton R; McConoughey S; Langley B; Estevez A; Huerta PT; Volpe B; Roy S; Sen CK; Gazaryan I; Cho S; Fink M; LaManna J
    J Mol Med (Berl); 2007 Dec; 85(12):1331-8. PubMed ID: 18043901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.